Hypoxia enhances aggressiveness of Cholangiocarcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 53-58

  Seubwai, Wunchana ^a,b   Kraiklang, Ratthaphol ^a,b   Wongkham, Chaisiri ^a,b   Wongkham, Sopit ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Bile duct cancer; BIRC5 survivin; Hypoxia; PCR array TFF1

Indexed keywords

CISPLATIN;

APOPTOSIS; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL HYPOXIA; CELL PROLIFERATION; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; TUMOR CELL LINE;

APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; CISPLATIN; HUMANS;

EID: 84874092831     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.53     Document Type: Article

References (29)

1. Adachi M, Taki T, Higashiyama M, et al (2000). Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res. 6, 96-101.
2. Anderson CD, Pinson CW, Berlin J, et al (2004). Diagnosis and treatment of cholangiocarcinoma. Oncologist. 9, 43-57.
3. Bennewith KL and Dedhar S (2011). Targeting hypoxic tumour cells to overcome metastasis. BMC cancer. 11, 504.
4. Brizel DM, Sibley GS, Prosnitz LR, et al (1997). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol, 38, 285-9.
5. Carl-McGrath S, Lendeckel U, Ebert M, et al (2005). The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol. 26, 17-24.
6. Chang Q, Liu ZR, Wang DY, et al (2004). Survivin expression induced by doxorubicin in cholangiocarcinoma. World J Gastroenterol. 10, 415-8.
7. Daduang J, Limpaiboon T, Daduang S (2011). Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12. Arch Med Sci. 7, 1013-6.
8. DeClerck K and Elble RC (2010). The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci. 15, 213-25.
9. Du M, Wang G, Ismail TM, et al (2012). S100p dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration. J Biol Chem. 287, 15330-44.
10. Gores GJ (2003). Cholangiocarcinoma: current concepts and insights. Hepatology, 37, 961-9.
11. Green SL and Giaccia AJ (1998). Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J Sci Am, 4, 218-23.
12. Hidaka S, Yasutake T, Fukushima M, et al (2003). Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells. Eur J Cancer, 39, 975-80.
13. Hinnis AR, Luckett JC, Walker RA (2007). Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer. 96, 639-45.
14. Hunsawong T, Singsuksawat E, In-Chon N, et al (2012). Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro. J Cancer Res Clin Oncol. 138, 1311-20.
15. Iba K, Albrechtsen R, Gilpin BJ, et al (1999). Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol. 154, 1489-501.
16. Javle MM, Tan D, Yu J, et al (2004). Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. Hepatogastroenterology, 51, 1653-7.
17. Kim K, Chie EK, Wu HG, et al (2011). High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis, 26, 1019-23.
18. Krepela E, Dankova P, Moravcikova E, et al (2009). Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol. 35, 1449-62.
19. Kveiborg M, Frohlich C, Albrechtsen R, et al (2005). A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res. 65, 4754-61.
20. Le Pabic H, Bonnier D, Wewer UM, et al (2003). ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology. 37, 1056-66.
21. Nordsmark M, Overgaard M, Overgaard J (1996). Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol, 41, 31-9.
22. Rockwell S, Dobrucki IT, Kim EY, et al (2009). Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med, 9, 442-58.
23. Thodeti CK, Frohlich C, Nielsen CK, et al (2005). ADAM12-mediated focal adhesion formation is differently regulated by beta1 and beta3 integrins. FEBS Lett. 579, 5589-95.
24. Thuwajit P, Chawengrattanachot W, Thuwajit C, et al (2007). Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion. Hepatol Res, 37, 295-304.
25. Sripa B, Leungwattanawanit S, Nitta T, et al (2005). Establishment and characterization of an opisthorchiasisassociated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol, 11, 3392-7.
26. Varner JA, Emerson DA, Juliano RL (1995). Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell, 6, 725-40.
27. Yamamoto H, Ngan CY, Monden M (2008). Cancer cells survive with survivin. Cancer Sci, 99, 1709-14.
28. Zhou GF, Ye F, Cao LH, et al (2000). Over expression of integrin alpha 5 beta 1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice. Mol Cell Biochem, 207, 49-55.
29. Zhu H, Wang Q, Hu C, et al (2011). High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy. Tumour Biol. 32, 1147-53.